SAT0144 A Phase I Pharmacokinetic Study Comparing SB2, An Infliximab Biosimilar, And Infliximab Reference Product (Remicade®) in Healthy Subjects: Table 1.

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 703.1-703 ◽  
Author(s):  
D. Shin ◽  
Y. Kim ◽  
Y.S. Kim ◽  
R. Fuhr ◽  
T. Körnicke
Keyword(s):  
Phase I ◽  
Pharmacokinetic Study ◽  
Healthy Subjects ◽  
Reference Product

scholarly journals A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade®) in Healthy Subjects

BioDrugs ◽  
2015 ◽  
Vol 29 (6) ◽  
pp. 381-388 ◽  
Author(s):  
Donghoon Shin ◽  
Youngdoe Kim ◽  
Yoo Seok Kim ◽  
Thomas Körnicke ◽  
Rainard Fuhr
Keyword(s):  
Phase I ◽  
Pharmacokinetic Study ◽  
Healthy Subjects ◽  
Reference Product

scholarly journals A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects

2016 ◽  
Vol 82 (1) ◽  
pp. 64-73 ◽  
Author(s):  
Yoon Jung Lee ◽  
Donghoon Shin ◽  
Youngdoe Kim ◽  
Jungwon Kang ◽  
Anke Gauliard ◽  
...  
Keyword(s):  
Pharmacokinetic Study ◽  
Healthy Subjects ◽  
Reference Product

scholarly journals A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects

2021 ◽  
Vol 53 (1) ◽  
pp. 375-383
Author(s):  
Hong Zhang ◽  
Xiaojiao Li ◽  
Jingrui Liu ◽  
Cuiyun Li ◽  
Min Wu ◽  
...  
Keyword(s):  
Phase I ◽  
Healthy Subjects ◽  
Reference Product
Sign in / Sign up

Export Citation Format

Share Document